Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 29% ± 10% | |
endothelial cell | 5 studies | 23% ± 6% | |
epithelial cell | 5 studies | 24% ± 6% | |
astrocyte | 5 studies | 24% ± 7% | |
GABAergic neuron | 4 studies | 33% ± 11% | |
glutamatergic neuron | 4 studies | 35% ± 11% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 8% | |
microglial cell | 3 studies | 21% ± 4% | |
interneuron | 3 studies | 37% ± 14% | |
neuron | 3 studies | 25% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 903.11 | 1445 / 1445 | 100% | 10.75 | 183 / 183 |
prostate | 100% | 1255.41 | 245 / 245 | 100% | 9.06 | 500 / 502 |
breast | 100% | 1141.48 | 459 / 459 | 100% | 8.79 | 1113 / 1118 |
brain | 99% | 649.12 | 2627 / 2642 | 100% | 9.53 | 705 / 705 |
bladder | 100% | 1151.14 | 21 / 21 | 99% | 8.85 | 501 / 504 |
thymus | 100% | 1395.84 | 653 / 653 | 99% | 9.39 | 601 / 605 |
ovary | 100% | 1545.66 | 180 / 180 | 99% | 8.37 | 426 / 430 |
uterus | 100% | 1433.03 | 170 / 170 | 99% | 9.44 | 453 / 459 |
stomach | 100% | 859.07 | 359 / 359 | 99% | 8.18 | 282 / 286 |
lung | 99% | 782.07 | 570 / 578 | 100% | 8.69 | 1154 / 1155 |
intestine | 100% | 1135.34 | 966 / 966 | 98% | 7.58 | 516 / 527 |
pancreas | 100% | 830.81 | 327 / 328 | 98% | 6.93 | 174 / 178 |
kidney | 100% | 773.89 | 89 / 89 | 94% | 6.70 | 846 / 901 |
adrenal gland | 100% | 915.76 | 258 / 258 | 90% | 3.81 | 207 / 230 |
liver | 100% | 564.50 | 226 / 226 | 89% | 4.49 | 361 / 406 |
skin | 100% | 991.46 | 1808 / 1809 | 86% | 7.25 | 404 / 472 |
spleen | 100% | 1303.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.48 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.65 | 1 / 1 |
muscle | 100% | 712.43 | 802 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 994.72 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 748.22 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 608.61 | 844 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 8.43 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 60% | 3.48 | 48 / 80 |
peripheral blood | 47% | 397.90 | 437 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030488 | Biological process | tRNA methylation |
GO_0106050 | Molecular function | tRNA 2'-O-methyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0008175 | Molecular function | tRNA methyltransferase activity |
Gene name | TRMT13 |
Protein name | tRNA:m(4)X modification enzyme TRM13 (EC 2.1.1.225) tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76) |
Synonyms | CCDC76 |
Description | FUNCTION: tRNA methylase which 2'-O-methylates cytidine(4) in tRNA(Pro) and tRNA(Gly)(GCC), and adenosine(4) in tRNA(His). . FUNCTION: tRNA methylase which 2'-O-methylates cytidine(4) in tRNA(Pro) and tRNA(Gly)(GCC), and adenosine(4) in tRNA(His). . FUNCTION: tRNA methylase which 2'-O-methylates cytidine(4) in tRNA(Pro) and tRNA(Gly)(GCC), and adenosine(4) in tRNA(His). . |
Accessions | ENST00000370141.8 [Q9NUP7-1] ENST00000370143.5 Q9NUP7 ENST00000482437.5 [Q9NUP7-2] ENST00000370139.1 Q5VVK9 Q5VVL2 |